SCYX FY 2020 Earnings — SCYNEXIS, Inc. Revenue & Financial Results | Market Cap Arena

SCYXSCYNEXIS, Inc.

$37M

FY 2020 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

-$303,000

Operating Income

-$51M

Net Income

-$55M

EPS (Diluted)

$-5.15

Cash Flow

Operating Cash Flow

-$49M

Free Cash Flow

-$49M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$103M

Total Liabilities

$80M

Stockholders' Equity

$23M

Cash & Equivalents

$93M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$121,000	-100.0%
Gross Profit	-$303,000	$121,000	-350.4%
Operating Income	-$51M	-$49M	-4.6%
Net Income	-$55M	-$54M	-2.7%